15 November 2016 - The holidays came early for the pharmaceutical industry this year.
With Donald Trump elected to the White House and Republicans controlling Congress, the companies that make your medicines can expect a friendlier environment in which to operate. And investors quickly responded by boosting drug and biotech stocks.